Journal Information
Vol. 41. Issue 7.
Pages 357-359 (July 2005)
Vol. 41. Issue 7.
Pages 357-359 (July 2005)
Editorial
Full text access
Health Care Professionals and the Pharmaceutical Industry
Visits
3691
F. Duce Gracia
Corresponding author
algc-duce@hcu-lblesa.es
Correspondence: F. Duce Gracia. Servicio de Alergia. Hospital Clínico Universitario Lozano Blesa. Avda. San Juan Bosco, 15. 50009 Zaragoza. España
Correspondence: F. Duce Gracia. Servicio de Alergia. Hospital Clínico Universitario Lozano Blesa. Avda. San Juan Bosco, 15. 50009 Zaragoza. España
Servicio de Alergia, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain
This item has received
Article information
Full text is only aviable in PDF
REFERENCES
[1]
M Angell.
The truth about the drug companies: how they deceive us and what to do about it, Casa Al Azar, (2004),
[2]
K Abbasi, R Smith.
No more free lunches.
BMJ, 326 (2003), pp. 1155-1156
[3]
R Moynihan.
Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: Entanglement.
BMJ, 326 (2003), pp. 1189-1192
[4]
R Moynihan.
Who pays for the pizza? Redefining the relationships between doctors and drug companies. 2: Disentanglement.
BMJ, 326 (2003), pp. 1193-1196
[5]
F Savater.
Ética para Amador, 45th ed., Ariel, (2004),
[6]
Caballé C. Declaraciones al periódico Expansión. Barcelona, 2004, 30 de septiembre.
[7]
F Davidoff, CD de Angelis, JM Drazen, J Hoey, L Hojgaard, R Horton, et al.
Sponsorship, authorship, and accountability.
Lancet, 358 (2001), pp. 854-856
[8]
J Collier, I Iheanacho.
The pharmaceutical industry as an informant.
Lancet, 369 (2002), pp. 1405-1409
[9]
E Wager.
How to dance with porcupines: rules and guidelines on doctors' relations with drug companies.
BMJ, 326 (2003), pp. 1196-1198
[10]
A Figueras, JR Laporte.
Failures of the therapeutic chain as a cause of drug ineffectiveness. Promotion, misinformation, and economics work better than needs.
BMJ, 326 (2003), pp. 895-896
[11]
JK Galbraith.
La cultura de la satisfacción, 7th ed., Ariel, (1997),
[12]
A Liberati, N Magrini.
Information from drug companies and opinion leaders.
BMJ, 326 (2003), pp. 1156-1157
[13]
PA Rochon, JH Gurwitz, M Cheung, JA Hayes, TC Chalmers.
Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal.
JAMA, 272 (1994), pp. 108-113
[14]
B Spilker, P Cuatrecasas.
La industria farmacéutica: una visión interior, Prous Science Publishers, (1992),
Copyright © 2005. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)